GENEVOLUTION
Business purpose.
La réalisation d'études sur des systèmes biologiques et en autres sciences physiques et naturelles en recherche et développement avec délivrance de résultats à des tiers du secteur pharmaceutique, cosmétiques, dispositifs médicaux,chimique et hospitalier. La caractérisation des cellules en cytogénétique et développement de nouveau modèle in vitro. Le commerce et fabrication d'équipement scientifique et technique,de machines spécialisées. Revente de matériel.Conseil et formation pour ses clients. Archivage selon les bonnes pratiques réglementaires (BPx), ou archivage de documents scientifiques.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Other research and experimental development on natural sciences and engineering (72.19Z)
- Sector
- Scientific research and development
- Headcount
- 10 to 19 employees
- Created
- 8 Jan 2018
- Share capital
- 7,145.00 EUR
- Registered with the trade register
- 6 Feb 2018
- Financial year end
- 31/12
- Establishments
- 4
Directors
- GAUTIER DECOCK 52 years old, 11/1974 Directeur general
- EMERSON AUDIT Commissaire aux comptes titulaire
- ISABELLE MOUCHE 60 years old, 11/1966 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- GENEVOLUTION PROSPECTIVE & INNOVATION via ISABELLE MOUCHE
- GENEVOLUTION TESTING via ISABELLE MOUCHE
Other companies at the same address
63 other company head offices are registered at this address.
Establishments
-
83522134200016 78711 MANTES-LA-VILLE
-
83522134200032 78440 PORCHEVILLE
-
83522134200024 78710 ROSNY-SUR-SEINE
Financial strength
Financial score
14 / 100 E
Confidence: medium · computed on the financial year ended 31 Dec 2024
- Equity to assets (2.4 %)
- 4.7 out of 30
- EBITDA margin
- data missing, component not taken into account
- Liquidity (142.9 %)
- 5.7 out of 20
- Debt (1,821.2 %)
- 0.0 out of 15
- Revenue trend (-100.0 %)
- 0.0 out of 10
formula fin-1.0
Legal score
98 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (8.8 years)
- 17.7 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2024 | 0 € | -100.0 % | 0 € | -180,971 € |
| 31 Dec 2021 | 699,794 € | first year on record | -134,825 € | -2,774 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de la fabrication et du commerce des produits à usage pharmaceutique, parapharmaceutique et vétérinaire du 1er juin 1989. Etendue par arrêté du 20 avril 1990 JORF 29 avril 1990
IDCC 1555 · repealed · 1 establishment · declared in July 2026
Legal notices
-
Filing of accounts 30 Jun 2025
- Court :
- Greffe du Tribunal des Activités Economiques de versailles
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250124, annonce n 10668 · Proof of publication (PDF)
-
Amendment 30 Jun 2025
- Court :
- Greffe du Tribunal des Activités Economiques de Versailles
- Amendment :
- Modification survenue sur l'administration, le capital.
BODACC B n 20250124, annonce n 4208 · Proof of publication (PDF)
-
Amendment 30 Mar 2023
- Court :
- Greffe du Tribunal de Commerce de Versailles
- Amendment :
- Modification survenue sur l'administration.
BODACC B n 20230063, annonce n 4926 · Proof of publication (PDF)
-
Amendment 2 Mar 2023
- Court :
- Greffe du Tribunal de Commerce de Versailles
- Amendment :
- Modification survenue sur le capital, transfert du siège social.
BODACC B n 20230043, annonce n 4269 · Proof of publication (PDF)
-
Filing of accounts 30 Dec 2022
- Court :
- Greffe du Tribunal de Commerce de versailles
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2021
BODACC C n 20220254, annonce n 3598 · Proof of publication (PDF)
-
Amendment 24 Oct 2021
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE VERSAILLES
- Amendment :
- Modification survenue sur l'activité.
BODACC B n 20210208, annonce n 1614 · Proof of publication (PDF)
-
Filing of accounts 22 Jul 2021
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE VERSAILLES
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2020
BODACC C n 20210141, annonce n 13684 · Proof of publication (PDF)
-
Amendment 3 Dec 2020
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE VERSAILLES
- Amendment :
- Modification survenue sur la dénomination.
BODACC B n 20200235, annonce n 3560 · Proof of publication (PDF)
-
Amendment 22 Apr 2020
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE VERSAILLES
- Amendment :
- transfert du siège social.
BODACC B n 20200079, annonce n 333 · Proof of publication (PDF)
Filings and accounts
- Formality 28 Jun 2025
- Formality 25 Jun 2025
Change history
- officer_appointed (empty) → Directeur general 9 Oct 2026
- officer_appointed (empty) → Commissaire aux comptes titulaire 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- capital 7145.00 → 5328.00 2 Oct 2026
- registered_address 4 Rue des Frères Montgolfiers 78710 Rosny-sur-Seine → 1560 Route de 40 sous 78630 Orgeval 2 Oct 2026
- capital (empty) → 7145.00 2 Oct 2026
- registered_address (empty) → 4 Rue des Frères Montgolfiers 78710 Rosny-sur-Seine 1 Oct 2026
Frequently asked questions about GENEVOLUTION
- What is the SIREN number of GENEVOLUTION?
- The SIREN number of GENEVOLUTION is 835221342. Its intra-community VAT number is FR02835221342.
- Where is the head office of GENEVOLUTION?
- Head office address: 1560 ROUTE DE 40 SOUS, 78630 ORGEVAL.
- When was GENEVOLUTION founded?
- GENEVOLUTION was founded on 8 Jan 2018.
- What does GENEVOLUTION do?
- Its declared main activity is: Other research and experimental development on natural sciences and engineering (NAF code 72.19Z).
- Who runs GENEVOLUTION?
- The officers listed in the register are GAUTIER DECOCK (Directeur general), EMERSON AUDIT (Commissaire aux comptes titulaire), ISABELLE MOUCHE (President de SAS).
- What is the revenue of GENEVOLUTION?
- The latest published revenue is 0 €, for the 2024 financial year.
- How many employees does GENEVOLUTION have?
- The declared headcount is 10 to 19 employees. Insee data for 2024.
- Is GENEVOLUTION subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.